Russia: Price of vital medicines goes up 10.3%
15 February 2016 (09:24)
UrBC, Yekaterinburg, February 15, 2016. The price of medicines rose by 10.3% in Russia last year; this was slightly below the overall inflation rate affecting all kinds of goods and services. Still, the price of non-vital medicines rose by as much as 14.2%, DMS Group’s research findings indicate.
Russia’s pharmaceutical market expanded by 8.5%, up to 1.25 trillion RUR last year. In dollar terms, however, sales dropped by 32% (down to $20.7bn) compared with the year 2014. In physical terms, sales decreased by 4.4%, down to 5.1bn packs/bottles.
‘The market has been gradually slowing down and stands at 1.25 trillion RUR at the moment; these slowing-down trends do not make a good forecast for the year 2016; the sales figures could reach 1.352 trillion RUR this year, and a 100bn-ruble increase is nearly nothing for this segment,’ says DSM Group’s CEO Sergei Shulyak.
State-funded purchases are also declining both in money and in physical terms.
Russia’s pharmaceutical market expanded by 8.5%, up to 1.25 trillion RUR last year. In dollar terms, however, sales dropped by 32% (down to $20.7bn) compared with the year 2014. In physical terms, sales decreased by 4.4%, down to 5.1bn packs/bottles.
‘The market has been gradually slowing down and stands at 1.25 trillion RUR at the moment; these slowing-down trends do not make a good forecast for the year 2016; the sales figures could reach 1.352 trillion RUR this year, and a 100bn-ruble increase is nearly nothing for this segment,’ says DSM Group’s CEO Sergei Shulyak.
State-funded purchases are also declining both in money and in physical terms.
 | Embed to Blog |  | Subscribe to Newsletter |  |